Calidi Biotherapeutics, Inc. (CLDI)
1.12
+0.02
(+1.82%)
USD |
NYAM |
Sep 21, 16:00
1.18
+0.06
(+5.36%)
After-Hours: 20:00
Calidi Biotherapeutics Total Liabilities (Quarterly) : 4.071M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.071M |
| March 31, 2026 | 4.656M |
| December 31, 2025 | 5.098M |
| September 30, 2025 | 6.831M |
| June 30, 2025 | 7.275M |
| March 31, 2025 | 7.765M |
| December 31, 2024 | 12.21M |
| September 30, 2024 | 16.46M |
| June 30, 2024 | 18.18M |
| March 31, 2024 | 21.98M |
| December 31, 2023 | 18.25M |
| Date | Value |
|---|---|
| September 30, 2023 | 19.68M |
| June 30, 2023 | 12.76M |
| March 31, 2023 | 8.153M |
| December 31, 2022 | 43.44M |
| September 30, 2022 | 10.37M |
| June 30, 2022 | 10.08M |
| March 31, 2022 | 14.45M |
| December 31, 2021 | 16.45M |
| September 30, 2021 | 20.98M |
| June 30, 2021 | 0.6832M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.661B |
| Anixa Biosciences, Inc. | 1.873M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.204M |
| Shareholders Equity (Quarterly) | 3.133M |
| Debt to Equity Ratio | 0.6199 |
| Current Ratio | 1.677 |
| Net Debt Paydown Yield | 9.76% |